CC
LLY icon

Centiva Capital’s Eli Lilly LLY Stock Holding History

Centiva Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.7M Sell
18,100
-35,400
-66% -$36.2M 0.19% 97
2026
Q1 		$49.2M Sell
53,500
-31,600
-37% -$32M 0.36% 50
2025
Q4 		$91.5M Buy
85,100
+46,600
+121% +$44.6M 0.74% 23
2025
Q3 		$29.4M Buy
38,500
+23,400
+155% +$17.4M 0.28% 65
2025
Q2 		$11.8M Buy
+15,100
New +$11.7M 0.19% 77
2025
Q1 		– Sell
-400
Closed -$309K – 1873
2024
Q4 		$309K Sell
400
-1,100
-73% -$911K 0.01% 1114
2024
Q3 		$1.33M Buy
1,500
+200
+15% +$180K 0.03% 681
2024
Q2 		$1.18M Sell
1,300
-4,700
-78% -$3.76M 0.02% 690
2024
Q1 		$4.67M Buy
6,000
+3,000
+100% +$2.14M 0.11% 129
2023
Q4 		$1.75M Sell
3,000
-9,100
-75% -$5.31M 0.04% 400
2023
Q3 		$6.5M Buy
12,100
+10,000
+476% +$5.15M 0.14% 122
2023
Q2 		$985K Sell
2,100
-3,000
-59% -$1.26M 0.02% 571
2023
Q1 		$1.75M Sell
5,100
-26,400
-84% -$8.9M 0.04% 434
2022
Q4 		$11.5M Buy
31,500
+3,400
+12% +$1.21M 0.33% 54
2022
Q3 		$9.09M Buy
28,100
+18,100
+181% +$5.73M 0.17% 71
2022
Q2 		$3.24M Sell
10,000
-17,000
-63% -$5.1M 0.08% 231
2022
Q1 		$7.73M Sell
27,000
-86,700
-76% -$22.3M 0.15% 93
2021
Q4 		$31.4M Buy
+113,700
New +$28.8M 0.65% 23
2020
Q3 		– Sell
-9,900
Closed -$1.63M – 798
2020
Q2 		$1.63M Sell
9,900
-12,000
-55% -$1.84M 0.1% 121
2020
Q1 		$3.03M Buy
21,900
+13,700
+167% +$1.88M 0.14% 108
2019
Q4 		$1.08M Buy
8,200
+3,900
+91% +$452K 0.05% 279
2019
Q3 		$481K Hold
4,300
– – 0.03% 339
2019
Q2 		$476K Sell
4,300
-30,100
-88% -$3.54M 0.03% 266
2019
Q1 		$4.46M Sell
34,400
-20,800
-38% -$2.53M 0.3% 51
2018
Q4 		$6.39M Buy
55,200
+16,500
+43% +$1.84M 0.5% 29
2018
Q3 		$4.15M Buy
38,700
+11,600
+43% +$1.16M 0.36% 45
2018
Q2 		$2.31M Buy
+27,100
New +$2.23M 0.49% 18

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Centiva Capital's LLY Position: Q2 2026 in Review

Centiva Capital reduced its Eli Lilly (LLY) stake by 27% in Q2 2026, selling an estimated $3.02M and leaving 7,922 shares worth $9.5M. The position accounts for 0.08% of the portfolio, ranked #177.

Centiva Capital first reported a position in LLY in Q4 2018 and has held it in 24 quarters since. The position peaked at $29.7M in Q3 2025. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Centiva Capital held 7,922 shares of Eli Lilly worth $9.5M as of Q2 2026.
  • Centiva Capital sold 2,955 Eli Lilly shares in Q2 2026, an estimated $3.02M.
  • Eli Lilly made up 0.08% of Centiva Capital's portfolio in Q2 2026, its #177 holding.
  • Centiva Capital first reported a position in Eli Lilly in Q4 2018 and has held it in 24 quarters since.
  • Centiva Capital's Eli Lilly position peaked at $29.7M in Q3 2025.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.